Elasomeran/davesomeran (Moderna Therapeutics)

N/A

Report date: 2025/07/18 17:54:01

Base Information

Drug NameElasomeran/davesomeran (Moderna Therapeutics)

Drug Alias NameSPIKEVAX BIVALENT ORIGINAL/ OMICRON BA.4-5 (elasomeran/ davesomeran) COVID-19 Vaccine

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineCell and gene therapy > Gene therapy > LNP +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)

Approved Indications in ChinaN/A

Original Approved Country/TerritoryAustralia

Original Approved Date2023/02/20

Country/TerritoryAustralia

CombinationsYes Elasomeran

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A